Klotho Neurosciences, Inc.
KLTO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28,793 | $38,366 | $6,262 | $13,134 |
| - Cash | $7,348 | $8,431 | $566 | $64 |
| + Debt | $0 | $0 | $1,768 | $272 |
| Enterprise Value | $21,445 | $29,935 | $7,464 | $13,342 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,718 | -$2,333 | -$1,680 | -$1,771 |
| % Margin | – | – | – | – |
| Net Income | -$2,896 | -$4,093 | -$2,234 | -$2,067 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.049 | -0.12 | -0.081 | -0.076 |
| % Growth | 59.4% | -47.8% | -6.4% | – |
| Operating Cash Flow | -$1,088 | -$1,968 | -$1,554 | -$944 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,088 | -$1,968 | -$1,554 | -$944 |